Getein Biotech announced plans to repurchase shares through centralized bidding. The total buyback amount will be no less than 50 million yuan and no more than 100 million yuan, with a maximum price of 12.51 yuan per share. The company expects to buy back between 4 million and 7.99 million shares, representing 0.79% to 1.58% of total share capital. The buyback period is 12 months following board approval, and the repurchased shares will be used for employee stock ownership plans or equity incentives. In the first quarter of 2026, the company reported revenue of 268 million yuan and net profit attributable to shareholders of 76.3 million yuan.
Getein Biotech IncCompany announces share buyback of 50-100 million yuan, a financial/valuation event.